Let’s start the year on a positive note!
Help tackle Canada’s dementia crisis and be the hero Canadians affected by dementia need right now.
Donate Now
We're here to help.
What information are you looking for?
Managing through COVID-19
Dementia doesn’t stop and neither do we. To get you through these difficult times, we have developed these helpful resources.
Find your Society
No matter where you live in Canada, you have a Society that you can be involved in. Your Society can help and support you with programs, services, education and resources tailored to you.
Newsletter
Sign up to Remember Me, news for supporters and friends of the Alzheimer Society of Canada.
Raise awareness
This month, learn more about dementia and its stark impact on Canadians.
Find out more10 easy ways to fight stigma
Race and dementia
At the Alzheimer Society of Canada, we work to change the lives of those living with dementia. However, we need to do more to combat systemic oppression. Here is how we are changing.
The Advisory Group of people living with dementia
The Alzheimer Society of Canada believes people with dementia should have a voice in the work that impacts them. We want to bring people from all over the country together to be part of the conversation by becoming a member of our Advisory Group.
The Alzheimer Society Research Program
On this page, learn more about the Alzheimer Society Research Program, including funding opportunities for researchers, when applications open and highlights from previous ASRP funded research.
Strategies for supporting brain health - A free, virtual public conference
Possibility, the pandemic and Pearl: Living well with dementia in the time of COVID-19
When COVID-19 locked down retirement and long-term care homes across Canada, Kim Neudorf was one of many Canadians who felt concern about how the changes would affect her mother.
Disappointing news for potential new treatment for Alzheimer’s
The Alzheimer Society of Canada is disappointed to hear that, after reviewing data from Phase 3 clinical trials, a U.S. Food and Drug Administration (FDA) advisory panel did not find conclusive evidence that a potential new treatment for Alzheimer’s was effective at reducing cognitive decline.
The results are in for the 2020 IG Wealth Management Walk for Alzheimer's
Canadians raised $5.1 million for the Walk at a critical time, when demand for services and supports continues to climb during a pandemic.
Read moreRegister for 2021
Medical assistance in dying
Canada's laws on medical assistance in dying are currently being debated in Parliament, and changes may be coming soon.
Get the latest updates.